Treanda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
Conditions:   Amyloidosis;   Light Chain (AL) Amyloidosis Interventions:   Drug: Bendamustine Hydrochloride;   Drug: Isatuximab Sponsors:   Tufts Medical Center;   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2021 Category: Research Source Type: clinical trials